These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34954155)

  • 1. TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer.
    Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
    Int J Biochem Cell Biol; 2022 Feb; 143():106140. PubMed ID: 34954155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X; Long Z; Cai H; Yu S; Wu J
    Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer" [Int. J. Biochem. Cell Biol. 143 (2022) 106140].
    Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
    Int J Biochem Cell Biol; 2022 Mar; 144():106157. PubMed ID: 35067396
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
    Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
    Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
    Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
    World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.
    Sun M; Zhou T; Jonasch E; Jope RS
    Biochim Biophys Acta; 2013 Jun; 1833(6):1489-97. PubMed ID: 23470959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
    Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
    Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
    Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
    Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.
    Gu L; Fullam A; McCormack N; Höhn Y; Schröder M
    Biochem J; 2017 Feb; 474(4):571-587. PubMed ID: 27980081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating DDX3 expression by serotonin 5-HT receptor 7 through phosphorylation of p53 via the AC-PKA-ERK signaling pathway.
    Kang LJ; Nguyen KVA; Eom S; Choi YJ; Nguyen CN; Lee J; Kim C; Lee S; Lee SG; Lee JH
    J Cell Biochem; 2019 Oct; 120(10):18193-18208. PubMed ID: 31172579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Zheng YZ; Li JY; Ning LW; Xie N
    Breast Cancer (Dove Med Press); 2022; 14():475-487. PubMed ID: 36578908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression.
    Chen WJ; Wang WT; Tsai TY; Li HK; Lee YW
    Sci Rep; 2017 Aug; 7(1):9411. PubMed ID: 28842590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
    Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
    Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
    J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.
    Vellky JE; McSweeney ST; Ricke EA; Ricke WA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28092-28101. PubMed ID: 33106406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.
    Li X; Jiang J; Wu Q; You T; Yang F
    Cancer Gene Ther; 2024 May; ():. PubMed ID: 38714850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
    Oliver PG; LoBuglio AF; Zhou T; Forero A; Kim H; Zinn KR; Zhai G; Li Y; Lee CH; Buchsbaum DJ
    Breast Cancer Res Treat; 2012 Jun; 133(2):417-26. PubMed ID: 21901385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.